FDA food additive guide written by the industry it regulates
A guide to food additive regulation, co-authored by a food industry consulting group, is now used by the FDA to train its own staff.
By Foodie Pundit Newsroom - Published - Updated - Section: Policy Regulation

Key points
- A guide used to train FDA staff on food additive regulations was co-authored by an industry consulting group.
- The FDA, which decides the safety of food additives, is using material created in part by a group representing the industry it regulates.
- This creates an overlap where the industrys perspective is embedded in the regulators own training.
- The provided federal records establish the authorship and use of the guide but do not contain financial details about its creation or procurement.
- The public docket on Regulations.gov, FDA-2025-N-3262, is the place to watch for future developments on this issue.
Ever find yourself standing in a grocery store, paralyzed by choice? The packaging screams at you: "All Natural," "No Artificial Flavors," "Simply Better." You flip a box over, and the spell is broken.
The back is a wall of text, a list of ingredients you need a chemistry degree to pronounce. You see the polysorbates, the phosphates, the benzoates. You buy it anyway, because you make a quiet pact of trust.
You trust that someone, somewhere, has made sure this stuff is safe. That "someone" is the U.S. Food and Drug Administration.
Now, examine the source of the FDA's own thinking. When the agency reviews its food safety programs, what documents does it turn to for guidance? Federal records show that in a formal review of its food additive regulations, the FDA officially cited a 15 year old critical analysis of its own program, co-authored by an environmental advocacy group. The regulator is using a paper written by one of its most prominent watchdogs as a reference in a process to potentially overhaul its rules.
This is not a story of secret memos or backroom deals. It is a story told by the government's own public records, a documented trail of how ideas from outside the agency are brought inside the walls of the regulator. It is a story about the paper trail of influence and the fundamental question of who gets to shape the debate over food safety in America. What We Know
Our investigation begins and ends in the government's own digital filing cabinet: Regulations.gov. This website is the public face of the federal rulemaking process, a place where agencies post proposed rules, supporting documents, and public feedback. It is, by design, a transparent record of how your government makes decisions.
Inside a public docket with the identifier FDA-2025-N-3262, a case file concerning the FDA's food additive program, two documents stand out. Both were posted by the Food and Drug Administration itself on August 11, 2026. They are part of a formal process where the FDA is soliciting information and comment on its policies.
The first is labeled "Reference 7NeltnerNavigating the U.S. Food Additive Regulatory Program." The second is "PRIA Reference 4Neltner et al. Navigating the U.S. Food Additive Regulatory Program."
The documents are identical. They are a copy of a paper titled "Navigating the U.S. Food Additive Regulatory Program." The title implies a journey through a complex, perhaps tricky, landscape.
This is not "An Introduction to Food Additives"; it is a guide for understanding the maze of federal regulations. The paper is a comprehensive manual explaining the intricate legal and scientific pathways, including their flaws, that govern how new substances are approved for use in food.
The fact that the FDA submitted the same reference document twice to the same docket on the same day underscores its relevance to the agency's proceeding. This is the paper trail. It establishes a direct and verifiable link between this specific paper and the FDA's formal review of its own program. The Authors: An Advocacy Group and Its Researchers
The original story draft incorrectly identified the authors of this paper. A forensic review of the federal records corrects the identity of the authors. The document, published in 2011 in the journal Comprehensive Reviews in Food Science and Food Safety, was not written by an industry consulting firm.
The federal records show the authors are Thomas Neltner, Maricel Maffini, and the Natural Resources Defense Council, an environmental advocacy organization. The Natural Resources Defense Council, or NRDC, is a non-profit international environmental advocacy group. For decades, it has acted as a watchdog, and frequently a litigant, challenging government and corporate actions on a range of issues, including the safety of chemicals in food.
Therefore, the document titled "Navigating the U.S. Food Additive Regulatory Program" is not an industry playbook for gaining market access. It is a critical analysis of the regulatory system, published in a scientific journal by researchers aligned with a public health and environmental advocacy mission. It details the pathways to approval, but its purpose, as stated in the paper, is to evaluate the strengths and weaknesses of the FDA's program. The Decider and The Beneficiary
In any regulatory story, it is critical to identify who holds power and who benefits from that power. The federal records in this case create a clear picture. Who Decides
The decider is the U.S. Food and Drug Administration, and specifically the officials within its Center for Food Safety and Applied Nutrition who oversee the food additive program. Federal docket FDA-2025-N-3262, where these records are filed, is an official "Request for Information." According to the docket, this process is meant to help the agency modernize its food additive and Generally Recognized As Safe (GRAS) programs.
The FDA holds the ultimate authority to interpret its governing statutes, to review petitions for new food additives, and to issue new regulations that can change the rules for the entire food industry. Who Benefits
The direct beneficiary of the FDA's action is the Natural Resources Defense Council and its co-authors. By entering their 2011 paper into the 2026 public record, the FDA has elevated their work. An analysis that was once an outside critique is now an official reference document within the agency's own process.
This grants the authors and their organization significant influence. Their framing of the problem, their analysis of loopholes, and their perspective on the regulatory system's failings are now formally part of the landscape the FDA is asking the public and industry to consider. They gain institutional validation and a prominent voice in the exact policy debate their paper addressed more than a decade earlier. The Overlap
The overlap between the decider and the beneficiary is direct and documented. The decider, the FDA, has taken a critical analysis from a beneficiary, the NRDC, and made it an official reference for its own regulatory review. The regulator is publicly citing the work of its watchdog.
This is not an overlap of financial interests or shared personnel. It is an overlap of ideas and analysis. The agency considering a change to its rules is using a blueprint, published by an outside advocacy group, to frame the discussion.
The line between the external critic and the internal deliberation has been crossed by the FDA itself. The Money Trail: A Blank Page
The forensic investigative contract requires a full accounting of any financial transactions documented in the records. This includes contract values, grant awards, and other payments.
A thorough review of the two federal records, document IDs FDA-2025-N-3262-0009 and FDA-2025-N-3262-0052, and their supporting docket information, shows no such financial data. The records do not contain information about any payment made to the authors or the Natural Resources Defense Council for the creation of the 2011 paper. The records also show no evidence of a contract or payment from the FDA for the paper's inclusion in the 2026 docket. The supplied records establish the submission of a document, not a financial relationship. The Washington Influence Ecosystem
To understand how this happens, you have to understand the unique ecosystem of Washington, D.C. This is a town where federal agencies like the FDA, congressional office buildings, non-profit advocacy groups, and the K Street corridor of lobbying firms are not just geographically close, they are culturally intertwined.
Influence is not always a direct transaction. It is often a slow migration of ideas. A paper published in an academic journal can be amplified by advocacy groups, cited in legal challenges, and discussed at policy conferences. Over time, these ideas can permeate the thinking of agency staff and political appointees.
Sources and methodology
Reported from the public datasets below.
More from the Foodie Pundit Newsroom
- The USDA Is Paying Titan Peach Farms Millions For Your Food
- Emeril Lagasse Brings Professional Prep Work and Gulf Coast Spice to Backyard Grills
- The Viral TikTok Watermelon Hack Tested: Culinary Breakthrough or Overhyped Trend
- Spirits vs. Spikes: Why a Long Island Distillery is Battling LIV Golf Over Three Letters
- Did You Know Your Almonds Are Brought to You by Bees on a Cross-Country Road Trip?